Eledon Pharmaceuticals (ELDN) Common Equity (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Common Equity of $44.8 million for Q1 2026, down 23.98% year-on-year from $58.9 million in Q1 2025, and down 44.79% on a QoQ basis from $81.1 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Common Equity data on file, last reported at $44.8 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity fell 23.98% year-over-year to $44.8 million; the trailing twelve-month figure through Mar 2026 stood at $44.8 million (down 23.98% YoY), and the FY2025 full-year result was $81.1 million, up 29.85% from the prior year.
- Common Equity for Q1 2026 stood at $44.8 million, down from $81.1 million in the prior quarter.
- Across five years, Common Equity topped out at $156.3 million in Q1 2022 and bottomed at -$70.4 million in Q1 2024.
- The 5-year median for Common Equity is $44.8 million (2026), against an average of $46.8 million.
- The widest annual swing landed in 2023, when Common Equity tumbled 303.83%; it then jumped 228.79% in 2024.
- A 5-year view of Common Equity shows it stood at $23.8 million in 2022, then sank by 303.83% to -$48.5 million in 2023, then surged by 228.79% to $62.4 million in 2024, then rose by 29.85% to $81.1 million in 2025, then sank by 44.79% to $44.8 million in 2026.
- The last three Common Equity figures came in at $44.8 million (Q1 2026), $81.1 million (Q4 2025), and $35.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 13.21 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 44.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.76 Mn |
| Dec 31, 2025 | 81.09 Mn |
| Sep 30, 2025 | 35.36 Mn |
| Jun 30, 2025 | 50.33 Mn |
| Mar 31, 2025 | 58.89 Mn |
| Dec 31, 2024 | 62.45 Mn |
| Sep 30, 2024 | 20.36 Mn |
| Jun 30, 2024 | -64.20 Mn |
| Mar 31, 2024 | -70.42 Mn |
| Dec 31, 2023 | -48.49 Mn |
| Sep 30, 2023 | 35.60 Mn |
| Jun 30, 2023 | 43.77 Mn |
| Mar 31, 2023 | 74.79 Mn |
| Dec 31, 2022 | 23.79 Mn |
| Sep 30, 2022 | 141.09 Mn |
| Jun 30, 2022 | 149.38 Mn |
| Mar 31, 2022 | 156.32 Mn |
| Dec 31, 2021 | 164.00 Mn |
| Sep 30, 2021 | 170.75 Mn |
| Jun 30, 2021 | 178.52 Mn |
| Mar 31, 2021 | 183.87 Mn |
| Dec 31, 2020 | 190.60 Mn |
| Sep 30, 2020 | 21.51 Mn |
| Jun 30, 2020 | 9.36 Mn |
| Mar 31, 2020 | 11.75 Mn |
| Dec 31, 2019 | 9.47 Mn |
| Sep 30, 2019 | 13.37 Mn |
| Jun 30, 2019 | 16.03 Mn |
| Mar 31, 2019 | 9.93 Mn |
| Dec 31, 2018 | 14.49 Mn |
| Sep 30, 2018 | 18.33 Mn |
| Jun 30, 2018 | 21.51 Mn |
| Mar 31, 2018 | 24.30 Mn |
| Dec 31, 2017 | 19.45 Mn |
| Sep 30, 2017 | 20.62 Mn |
| Jun 30, 2017 | 23.44 Mn |
| Mar 31, 2017 | 23.36 Mn |
| Dec 31, 2016 | -2.70 Mn |
| Sep 30, 2016 | 30.26 Mn |
| Jun 30, 2016 | 38.88 Mn |
| Mar 31, 2016 | 51.41 Mn |
| Dec 31, 2015 | 2.78 Mn |
| Sep 30, 2015 | 71.90 Mn |
| Jun 30, 2015 | 82.75 Mn |
| Mar 31, 2015 | 90.90 Mn |
| Dec 31, 2014 | 103.50 Mn |
| Sep 30, 2014 | 101.61 Mn |
| Dec 31, 2013 | -55.27 Mn |